Clinical trial • Phase I • Immunology | Respiratory | Dermatology | Gastroenterology
CKD-706 for Atopic dermatitis | Asthma | Chronic rhinosinusitis with nasal polyposis | Eosinophilic esophagitis | Prurigo nodularis | Chronic obstructive pulmonary disease
Phase I trial of CKD-706 for Atopic dermatitis | Asthma | Chronic rhinosinusitis with nasal polyposis | Eosinophilic esophagitis | Prurigo nodularis | Chr…
Overview
- Trial Therapeutic Area
- Immunology | Respiratory | Dermatology | Gastroenterology
- Trial Disease
- Atopic dermatitis | Asthma | Chronic rhinosinusitis with nasal polyposis | Eosinophilic esophagitis | Prurigo nodularis | Chronic obstructive pulmonary disease
- Trial Stage
- Phase I
- Drug Modality
- Monoclonal antibody
Key dates
- Initial CTIS Submission Date
- 29-10-2025
- First CTIS Authorization Date
- 09-01-2026
Trial design
CKD-706 compared with US-Dupixent® and EU-Dupixent® (drug names stated; doses and schedules not specified in the provided data)-controlled Phase I trial across 1 site in Germany.
- Comparator
- CKD-706 compared with US-Dupixent® and EU-Dupixent® (drug names stated; doses and schedules not specified in the provided data)
- Target Sample Size
- 519
- Trial Duration For Participant
- 273
Recruitment
- Planned Sample Size
- 519
- Recruitment Window Months
- 9
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 335
Germany
- Earliest CTIS Part Ii Submission Date
- 11-12-2025
- Latest Decision Or Authorization Date
- 09-01-2026
- Processing Time Days
- 29
- Number Of Sites
- 1
- Number Of Participants
- 335
Sites
- Site Name
- Klinikum Westend Haus 31, Spandauer Damm 130, Charlottenburg
- Department Name
- 01
- Contact Person Name
- Camila Rincon
- Contact Person Email
- Camila.Rincon@parexel.com
Sponsor
Primary sponsor
- Full Name
- Chong Kun Dang Pharmaceutical Corp.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Korea, Republic of
Contract research organisations
- Name
- PAREXEL International GmbH
- Responsibilities
- Site contact / clinical operations (contact provided in trial site record: Camila.Rincon@parexel.com)
Investigational products
- Investigational Product Name
- CKD-706
- Modality
- Monoclonal antibody
- Investigational Product Name
- US-Dupixent®
- Modality
- Monoclonal antibody
- Investigational Product Name
- EU-Dupixent®
- Modality
- Monoclonal antibody
Related trials
Other published trials that may interest you.